- Poster presentation
- Open Access
Parathyroid adenomas – a cluster of boys
© Titmuss et al; licensee BioMed Central Ltd. 2015
- Published: 28 April 2015
- Primary Hyperparathyroidism
- Parathyroid Adenoma
- Renal Calculus
- Mild Developmental Delay
- Slight Female Preponderance
Primary hyperparathyroidism is rare in children and adolescents, representing 1% of all cases, with a slight female preponderance [1–3]. 3-5% of cases are hereditary and may represent the initial clinical manifestation of multiple endocrine neoplasia type 1 (MEN1).
Over the last 30 years, ten cases of primary hyperparathyroidism have presented to our hospital, all aged 11-14 years, with nine cases being male, and eight cases over the last six years. Presenting features included headache and blurred vision in five patients, abdominal pain and nausea (in three), renal calculi (in four), generalized bone pain (in three) and two asymptomatic. One patient had received radiation for acute lymphoblastic leukaemia. Other history included ADHD (in one patient), mild developmental delay (in one), depression (in one) and fine motor difficulties (in one). No patients had a significant family history.
Peak corrected calcium level ranged between 3.12-3.65 mmol/L (2.1-2.65), peak PTH level 6.9-154 pmol/L (1-7), and urine calcium creatinine ratio 0.47-2.76mM/mM (0.04-0.7). Serum alkaline phosphatase was 212-549U/L (80-355), and normal in three of the renal calculi patients. Bony changes were seen in three patients, with flaring of clavicles and widening of epiphyses, decreased phalangeal cortical density and osteopenia. 25-OH calciferol was low at 27-39nmol/L (>50) in 3 of 7 patients in whom it was measured.
Thyroid ultrasound detected suspicious lesions in seven patients and was normal in three patients. Sestamibi scan was negative for three patients (with one ectopic gland) and indicated a single overactive gland in seven patients. All patients had a positive result from at least one modality.
All patients underwent surgical resection, with a single benign parathyroid adenoma identified in each case. The only significant post-operative issues were initial hypocalcaemia (lowest cCa 1.8mmol/L) in eight patients, requiring management with calcitriol and elemental calcium. There was normalisation of calcium over several weeks post-operatively, with gradual weaning of supplementation required. In all, post-operative PTH level was suppressed. MEN1 screening has been negative for all patients.
This case series illustrates the difficulties involved in the diagnosis of parathyroid adenoma in children, requiring both scintigraphy and ultrasound. Scintigraphy has been reported in the literature to have 88% sensitivity, lower in our case series, compared to 78% sensitivity for ultrasound . The gender mix of our cases differs significantly from other reported case series, being predominantly male [3, 5] and there is a suggestion of increasing incidence over recent years.
- Sneider MS, Solorzano CC, Montano RE, et al: Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?. J Surg Res. 2009, 155: 100-3. 10.1016/j.jss.2008.07.041.View ArticlePubMedGoogle Scholar
- Paunovic I, Zivaljevic V, Stojanic R, et al: Primary hyperparathyroidism in children and young adults: a single institution experience. Acta Chir Belg. 2013, 113: 35-9.PubMedGoogle Scholar
- Romero Arenas MA, Morris LF, Rich TA, et al: Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of paediatric patients with primary hyperparathyroidism. J Ped Surg. 2014, 49: 546-550. 10.1016/j.jpedsurg.2013.11.059.View ArticleGoogle Scholar
- Eslamy HK, Ziessman HA: Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc Sestamibi SPECT and SPECT/CT. Radiographics. 2008, 28: 1461-1476. 10.1148/rg.285075055.View ArticlePubMedGoogle Scholar
- Kundel A, Thompson GB, Richards ML, et al: Pediatric Endocrine Surgery: A 20 year experience at the Mayo Clinic. J Clin Endocrin Metab. 2014, 99 (2): 399-406. 10.1210/jc.2013-2617.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.